Marine Derived Pharmaceuticals Market

Marine-derived Pharmaceuticals Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The marine-derived pharmaceuticals market is expected grow at a CAGR of 7.2% from 2023 to 2032.

Increased burden for existing resources and treatments and a large availability of undiscovered chemicals with unique activity are driving research and growth in the marine-derived drugs market.

Companies majorly involved in the development and sale of marine-derived pharmaceuticals are Amway Corp., BASF SE, BioMarin Pharmaceutical inc., GlaxoSmithKline Plc, Guardian Industries Corp., Koninklijke DSM NV, Pfizer Inc., Pharma Marine AS, Seagen Inc., etc.

The North America region has a third of the global marine derived pharmaceutical market and will show significant growth across the forecast period of the next decade. The United States and Canada are the largest markets for experimental and approved marine pharmaceutical products.

As mentioned earlier, major segments seeing exponential growth in the marine derived pharmaceutical markets are oncology treatment and anti-infection medications.

Based on activity, the marine derived pharmaceuticals market is segmented into Cancer treatment, Antibiotic, Nutritional and others.

Marine derived pharmaceuticals are bioactive compounds that are extracted from animals or plants of marine environment.